Cage Bio

About:

Cage Bio develops novel products for dermatology, inflammation, and immunology.

Twitter/X: CageBioInc

Top Investors: Propel(X)

Description:

Cage Bio is a privately-held clinical-stage company exploiting its proprietary deep eutectic ionic liquid platform to develop novel products for dermatology, inflammation, and immunology. The company's mission is to develop highly effective topical products for localized treatment thereby minimizing side effects from systemic exposure. Cage Bio is headquartered in San Carlos, California.

Total Funding Amount:

$12.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Carlos, California, United States

Founded Date:

2016-01-01

Contact Email:

admin(AT)cagebio.com

Founders:

Nitin Joshi, Ravi Srinivasan, Samir Mitragotri

Number of Employees:

1-10

Last Funding Date:

2021-02-16

IPO Status:

Private

Industries: